{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:58:08Z","timestamp":1768535888241,"version":"3.49.0"},"reference-count":23,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>A 65-year-old man presented with symptoms of severe subcutaneous bleeding in his arm, which led to compartment syndrome requiring fasciotomy and massive blood transfusion protocol. Medical history was significant for history of autoimmune thyroid disease. Workup revealed elevated partial thromboplastin time, decreased factor VIII levels and elevated factor VIII inhibitor levels. He was worked up for causes of acquired haemophilia A and was found to have an elevated SARS-CoV-2 antibody level. Given his negative workup for other secondary aetiologies, we suspect that the cause of his haemophilia A was from his SARS-CoV-2 infection, which has been observed previously in various case reports.<\/jats:p>","DOI":"10.1136\/bcr-2021-242884","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T15:57:32Z","timestamp":1626796652000},"page":"e242884","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Severe acquired haemophilia associated with asymptomatic SARS-CoV-2 infection"],"prefix":"10.1136","volume":"14","author":[{"given":"Kevin Y","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis T","family":"Roarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shams A","family":"Shakil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"2021072008551253000_14.7.e242884.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(98)80049-8"},{"key":"2021072008551253000_14.7.e242884.2","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1148\/radiol.2020201561","article-title":"Acute pulmonary embolism in patients with COVID-19 at CT angiography and relationship to D-dimer levels","volume":"296","author":"L\u00e9onard-Lorant","year":"2020","journal-title":"Radiology"},{"key":"2021072008551253000_14.7.e242884.3"},{"key":"2021072008551253000_14.7.e242884.4","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000431"},{"key":"2021072008551253000_14.7.e242884.5","doi-asserted-by":"crossref","unstructured":"Duque Ortega JG . Acquired hemophilia and tuberculosis: case report and literature review. HTIJ 2017;5 https:\/\/medcraveonline.com\/HTIJ\/acquired-hemophilia-and-tuberculosis-case-report-and-literature-review.html doi:10.15406\/htij.2017.05.00135","DOI":"10.15406\/htij.2017.05.00135"},{"key":"2021072008551253000_14.7.e242884.6","first-page":"001678","article-title":"Acquired haemophilia A in association with influenza A and urinary tract infection","volume":"7","author":"Pe\u00f1a-Mu\u00f1oz","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"2021072008551253000_14.7.e242884.7","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25865","article-title":"The first case of acquired hemophilia A associated with SARS-CoV-2 infection","volume":"95","author":"Franchini","year":"2020","journal-title":"Am J Hematol"},{"key":"2021072008551253000_14.7.e242884.8","doi-asserted-by":"crossref","unstructured":"Zhang Y , Xiao M , Zhang S , et al . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med Overseas Ed 2020;382:e38. doi:10.1056\/NEJMc2007575","DOI":"10.1056\/NEJMc2007575"},{"key":"2021072008551253000_14.7.e242884.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x"},{"key":"2021072008551253000_14.7.e242884.10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-238118"},{"key":"2021072008551253000_14.7.e242884.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-1947-8-469","article-title":"Acquired haemophilia a associated with autoimmune thyroiditis: a case report","volume":"8","author":"Pathirana","year":"2014","journal-title":"J Med Case Rep"},{"key":"2021072008551253000_14.7.e242884.12","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/bjh.16846","article-title":"Evans syndrome in a patient with COVID-19","volume":"190","author":"Li","year":"2020","journal-title":"Br J Haematol"},{"key":"2021072008551253000_14.7.e242884.13","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.432"},{"key":"2021072008551253000_14.7.e242884.14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-0038-1650169","article-title":"A survey of 215 non-hemophilic patients with inhibitors to factor VIII","volume":"45","author":"Green","year":"1981","journal-title":"Thromb Haemost"},{"key":"2021072008551253000_14.7.e242884.15","first-page":"196","article-title":"Hiv-Associated and idiopathic-acquired haemophilia A: a single-centre case series from Cape town, South Africa","volume":"78","author":"Shein","year":"2020","journal-title":"Neth J Med"},{"key":"2021072008551253000_14.7.e242884.16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.12746\/swrccc.v6i23.465","article-title":"Acquired factor VIII inhibitor associated with chronic untreated hepatitis C","volume":"6","author":"Shredi","year":"2018","journal-title":"The Southwest Respiratory and Critical Care Chronicles"},{"key":"2021072008551253000_14.7.e242884.17","doi-asserted-by":"crossref","first-page":"e926728","DOI":"10.12659\/AJCR.926728","article-title":"An 89-year-old man with COVID-19-Associated coagulopathy presenting with a prolonged partial thromboplastin time, lupus anticoagulant, and a high titer of factor VIII inhibitor","volume":"21","author":"Ghafouri","year":"2020","journal-title":"Am J Case Rep"},{"key":"2021072008551253000_14.7.e242884.18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/trf.16254","article-title":"De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection","volume":"61","author":"Olsen","year":"2021","journal-title":"Transfusion"},{"key":"2021072008551253000_14.7.e242884.19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02104-20","article-title":"Comparison of the clinical performances of the Abbott Alinity IgG, Abbott architect IgM, and Roche Elecsys total SARS-CoV-2 antibody assays","volume":"59","author":"Harley","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2021072008551253000_14.7.e242884.20","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jiph.2020.08.003","article-title":"Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children","volume":"13","author":"Rehman","year":"2020","journal-title":"J Infect Public Health"},{"key":"2021072008551253000_14.7.e242884.21","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6940e1"},{"key":"2021072008551253000_14.7.e242884.22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00481-y","article-title":"Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need","volume":"6","author":"Jin","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2021072008551253000_14.7.e242884.23","first-page":"1","article-title":"SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19","volume":"10","author":"Gl\u00fcck","year":"2021","journal-title":"Infection"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-242884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:14:21Z","timestamp":1672877661000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-242884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":23,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,20]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bcr-2021-242884"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-242884","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}